ライフサイエンスコーパス: envelope protein

1 nd all of these mapped to domain A of the E2 envelope protein.

2 dity of the Abs that recognize the SIV gp120 envelope protein.

3 he mutant Gag protein biotinylated the HIV-1 Envelope protein.

4 lly important domains, each from a different envelope protein.

5 n (chi) to replace the function of the viral envelope protein.

6 rypsin sensitive and not attributable to the envelope protein.

7 the level of antibody responses to the gp120 envelope protein.

8 doparticle, and the ectodomain of the HCV E2 envelope protein.

9 spike, but not on soluble forms of the same envelope protein.

10 and compared it to currently used unblocked envelope protein.

11 ducing the same F108A mutation into the ZIKV envelope protein.

12 volunteers vaccinated with a recombinant HIV envelope protein.

13 y of filoviruses to tolerate swapping of the envelope protein.

14 ulated genes, most of which encoded putative envelope proteins.

15 determinant A (crdA), transport, binding and envelope proteins.

16 cross-neutralizing vaccine aimed at the HCV envelope proteins.

17 utilize mixtures of different soluble HIV-1 envelope proteins.

18 the cytoplasmic Env precursor to the virion envelope proteins.

19 ected multiple gp160 DNAs and gp140-trimeric envelope proteins.

20 aries, depending on the type of pseudotyping envelope proteins.

21 to alleviate stress caused by misfolded cell envelope proteins.

22 tion to provide HDV with HBV surface antigen envelope proteins.

23 heterodimers composed of the gp120 and gp41 envelope proteins.

24 eptide (SP) at the N terminus of MMTV Rem or envelope proteins.

25 protein B (ApoB), ApoE, and the HCV core and envelope proteins.

26 ttachment/entry governed by the hepadnavirus envelope proteins.

27 ncluding cytoplasmic distribution of nuclear envelope proteins.

28 h inversely correlated with the level of the envelope proteins.

29 ine based on virus-like particles expressing envelope proteins.

30 encoding putative surface and transmembrane envelope proteins.

31 infection and propagation of which depend on envelope proteins.

32 hedrovirus (AcMNPV) was shown to traffic ODV envelope proteins.

33 e interactions of M with the viral spike and envelope proteins.

34 Mutations in the synaptic nuclear envelope protein 1 (SYNE1) gene have been reported to ca

35 Mutations in the synaptic nuclear envelope protein 1 (SYNE1) gene, located on chromosome 6

36 ng mucin, erythropoietin, fetuin, and an HIV envelope protein, 1086.C gp120.

37 Hypervariable region 1 (HVR1) within viral envelope protein 2 (E2) is involved in the usage of SR-B

38 , either by cluster of differentiation 81 or envelope protein 2-specific antibodies or convalescent s

39 The E1 envelope protein, a class II fusion protein, contains th

40 en identified in the hepatitis B virus (HBV) envelope proteins: a pre-S1 receptor-binding site and an

41 f patches and extensions on the PM where the envelope proteins accumulate.

42 ed that most antibodies that reacted to DENV envelope protein also reacted to ZIKV.

43 The monoclonal TSAbs recognize 37-kDa envelope proteins, also recognized by rFab germline.

44 estral sequence and reconstruct a functional envelope protein (ancHTenv) that could support infection

45 riety of microscopy techniques to follow the envelope protein and a host cell PM protein during buddi

46 th both high titers of antibodies to the SIV envelope protein and durable effector SIV-specific CD8(+

47 s) with fluorescent protein labels on the E2 envelope protein and exploited them to characterize viru

48 sential for interaction with the Lassa virus envelope protein and subsequent infection.

49 rinuclear, neuronal regions expressing viral envelope protein and the endoplasmic reticulum (ER)-asso

50 pe "KoRV-B." KoRV-B is most divergent in the envelope protein and uses a host receptor distinct from

51 nvestigated the relative contribution of HCV envelope proteins and apolipoprotein E in the HS-binding

52 tigate the intracellular association between envelope proteins and apolipoproteins B and E (ApoB and

53 r show that the centrosome, SUN-KASH nuclear envelope proteins and Dnmt2 (also known as Mt2) are requ

54 hat a single Fab molecule binds across three envelope proteins and engages three functionally importa

55 nd point out that interactions between viral envelope proteins and host cell receptors can have biolo

56 ional groups are hypothetical proteins, cell envelope proteins and proteins involved in DNA metabolis

57 ogens such as viruses and bacteria use their envelope proteins and their adhesin lectins to recognize

58 t protein tags on one of the viral membrane (envelope) proteins and used a variety of microscopy tech

59 rsor to the membrane protein upstream of the envelope protein, and our rVSV-ZIKV constructs showed ef

60 Although envelope proteins are known to carry glycans, little is

61 We determined that the SGHBV envelope proteins are responsible for this property of S

62 tion is profoundly suppressed) if functional envelope proteins are supplied from HBV integrants.

63 risk associated with ZIKV vaccines using the envelope proteins as immunogens).

64 ent nanodiamonds (FNDs) coated with vaccinia envelope proteins as the model system.

65 TNC bound the HIV-1 Envelope protein at a site that is induced upon engageme

66 ry-based sorting of single B cells using HIV envelope protein baits.

67 ndent B cell epitopes and the limitations of envelope protein-based antibody screening.

68 vious reports indicate that some HIV-1 gp120 envelope proteins bind to and signal through alpha4beta7

69 ents showed that HEPC74 primarily blocks HCV envelope protein binding to CD81, while HEPC98 primarily

70 and then intratracheally (i.t.), followed by envelope protein boosting, elicits broad cellular immuni

71 ter viruses pseudotyped with R5-tropic gp120 envelope proteins but had minimal effects on reporter vi

72 gation of stress generated by misfolded cell envelope proteins but promotes expression of genes invol

73 mechanism of glycan recognition on the gp120 envelope protein by these antiviral lectins may therefor

74 The uncleaved ectodomain of the envelope protein, called gp140, has also been made as a

75 -specific human endogenous retroviral (HERV) envelope proteins, called syncytins, and their widely-di

76 r changes in the expression of these nuclear envelope proteins can result in a broad range of human d

77 y assays, produced by shared epitopes in the envelope proteins, can complicate the serological diagno

78 ction can produce functional small and large envelope proteins capable of the formation of infectious

79 Viral envelope proteins catalyze this critical membrane fusion

80 region I of the cytoplasmic domain of the E2 envelope protein (cdE2-RI) and K252 of Cp, part of the C

81 behavior of ribosomes synthesizing the inner envelope protein CemA indicates that sorting signals for

82 Bacterial cell envelope protein (CEP) complexes mediate a range of proc

83 in (a "class I" fusogen) and West Nile virus envelope protein ("class II").

84 nd differed only by the HBV variant-specific envelope proteins coating the particles.

85 The cleaved, trimeric envelope protein complex is the only neutralizing antibo

86 t proteins (that is, LptA-LptG) form a trans-envelope protein complex responsible for the transport o

87 ocessing and trafficking requirements of CMV envelope protein complexes and provide an example of the

88 g 1 (CHUP1) that encodes a chloroplast outer envelope protein constitutively induces stromules in the

89 -bonding interaction network within the ZIKV envelope protein contribute to stability differences bet

90 In this study, we determined that the envelope proteins contribute to the ability of hepadnavi

91 to the third variable region (V3) of the HIV envelope protein correlate with reduced HIV infection ra

92 e spatially distinct epitopes in DIII of the envelope protein corresponding to the lateral ridge (ZV-

93 We show that the Arabidopsis nuclear envelope protein, CPR5, negatively regulates ETI and the

94 Vaccinia virus (VACV) envelope protein D8 is one of three glycosaminoglycan ad

95 An analysis of 11 tegument and envelope proteins defined the composition and plasticity

96 dromedaries with different soluble trimeric envelope proteins derived from HIV-1 subtype C.

97 peptide derived from the stem region of ZIKV envelope protein, designated Z2, potently inhibits infec

98 cture epitopes near the hinge region between envelope protein domain I (EDI) and EDII.

99 We applied this method to the envelope protein domain III (ED3) of two medically impor

100 uncover a full-length endogenous retrovirus envelope protein, dubbed HEMO [human endogenous MER34 (m

101 the surface of capsids and interact with the envelope proteins during virion formation.

102 fusion loop epitope (FLE), a segment of the envelope protein E that is buried at the interface of th

103 alizing antibodies are directed to the viral envelope protein (E) and an accepted correlate of immuni

104 The JEV envelope protein (E) facilitates cellular attachment and

105 osorbent assays (MAC/GAC-ELISAs) targeted at envelope protein (E) of dengue viruses (DENV), West Nile

106 drives the transmembrane anchor of the viral envelope protein (E) toward the fusion loop, buried in t

107 The West Nile Virus (WNV) envelope protein, E, promotes membrane fusion during vir

108 tensive intergenotypic sequence diversity of envelope proteins E1 and E2 of HCV and shielding of impo

109 ced with the transmembrane domain of the HCV envelope proteins (E1 or E2) were efficiently coassemble

110 ture-derived HCV (HCVcc) harboring authentic envelope proteins (E1/E2) has hindered neutralization in

111 cell activation via competition between its envelope protein E2 and Lck following TCR engagement.

112 Recently, the crystal structure of the viral envelope protein E2 region was resolved as well as how E

113 coding West Nile virus (WNV) premembrane and envelope proteins efficiently produced subviral particle

114 Ectopic expression of the nuclear envelope protein emerin, which is mislocalized in Lmna m

115 y more MAbs neutralized DENV than reacted to envelope protein, emphasizing the significance of virion

116 d that a critical amino acid mutation in the envelope protein enhances the production of VLPs.

117 In particular, its envelope protein ENV can mediate injury to specific cell

118 restriction mechanism that targets the HIV-1 envelope protein Env, but is overcome by Vpr and its int

119 mmune responses generated by targeting HIV-1 envelope protein (Env gp140) to either CD40 or LOX-1, tw

120 Human immunodeficiency virus-1 (HIV-1) envelope protein (Env) and influenza hemagglutinin (HA)

121 meric units of Moloney murine leukemia virus envelope protein (Env) are activated in relation to each

122 The viral envelope protein (ENV) facilitates the earliest events o

123 or targets on the gp120 component of the HIV envelope protein (Env) for broadly neutralizing antibodi

124 The envelope protein (Env) from the CasBrE murine leukemia v

125 Syncytin genes are fusogenic envelope protein (env) genes of retroviral origin that h

126 The HIV-1 envelope protein (Env) has evolved to subvert the host i

127 The HIV-1 envelope protein (Env) is heavily glycosylated, with app

128 o of the HIV-1 structural protein Gag to the envelope protein (Env) is important for maximal virion i

129 The envelope protein (Env) of Jaagsiekte sheep retrovirus (J

130 Here, we characterize the envelope protein (ENV) of the virus to define how it med

131 to variable regions 1 and 2 (V1V2) of HIV-1 envelope proteins (Env) correlated inversely with the ra

132 HIV-1 envelope proteins (Envs) play a critical role in HIV inf

133 ly immunized with recombinant trimeric HIV-1 envelope proteins (Envs) was screened directly for HIV-1

134 human immunodeficiency virus type 1 (HIV-1) envelope protein expressed by infected cells mobilize an

135 ring single B cells that recognize the HIV-1 envelope protein expressed on the surface of transfected

136 Subsequent restoration of envelope protein expression led to a decrease (>50%) in

137 Furthermore, envelope proteins extracted from the viral membrane with

138 H. ducreyi, does not regulate homologues of envelope protein folding factors but does downregulate g

139 Viruses are known to use virally encoded envelope proteins for cell attachment, which is the very

140 licon particle (VRP) or by a recombinant HIV envelope protein formulated with MF59 adjuvant, anti-env

141 ontains truncated, recombinant, Dengue virus envelope protein from all four Dengue virus serotypes (D

142 lained in whole or in part by the release of envelope protein from expressing cells into the supernat

143 f 2H12-Fab in complex with domain III of the envelope protein from three dengue serotypes have been d

144 In 2013, envelope proteins from a pestivirus and hepatitis C viru

145 patitis delta virus (HDV), requires only the envelope proteins from HBV in order to maintain persiste

146 V) was investigated for its contributions to envelope protein function and virion infectivity.

147 kDa leader peptide (LP18) of the foamy virus envelope protein (FVenv) as a new substrate for intramem

148 apsid and a fluorescently tagged form of the envelope protein gD, we found that similar numbers of gD

149 tegument proteins VP16, VP1/2 and pUL37, and envelope protein gD.

150 Their envelope protein gene emerged de novo, leading to a majo

151 , designated nackednaviruses, which lack the envelope protein gene, but otherwise exhibit key charact

152 Testing replicons expressing representative envelope protein genes from all major HCV genotypes, we

153 ion of infectious HCV particles with primary envelope protein genes from GT 1 and GT 2-infected patie

154 meric viruses containing the premembrane and envelope protein genes of DENV-1, DENV-3, and DENV-4 gen

155 Syncytins are envelope protein genes of retroviral origin that have be

156 In silico search for envelope protein genes with full-coding capacity within

157 -D has been shown to bind to HIV via the HIV envelope protein gp120 and inhibit infectivity in vitro.

158 Previous studies demonstrated that HIV-1 envelope protein gp120 binds and signals through alpha4b

159 The HIV-1 envelope protein gp120 binds to and signals through inte

160 HIV-1 envelope protein gp120 has been extensively studied for

161 dole core heterocycles that target the viral envelope protein gp120 has been prepared.

162 The HIV-1 envelope protein gp120 is both the target of neutralizin

163 To initiate HIV entry, the HIV envelope protein gp120 must engage its primary receptor

164 Envelope protein gp120 of human immunodeficiency virus (

165 The HIV-1 envelope protein gp120 plays a major role in binding and

166 and its co-crystal structure with the HIV-1 envelope protein gp120 revealed a new loop-based mechani

167 as inhibitors to prevent the binding of HIV envelope protein gp120 to DC-SIGN at nanomolar concentra

168 recognized by 2G12 as tightly as is the HIV envelope protein gp120, and they are the first construct

169 In the HIV-1 envelope protein gp120, they overlap with known antigeni

170 it HIV by binding to the highly glycosylated envelope protein gp120.

171 network of a recombinant monomer of the HIV envelope protein gp120.

172 antibodies targeting the V1/V2 loops of the envelope protein gp120.

173 agents dichloroacetate and paclitaxel or HIV envelope protein gp120.

174 es in the spinal cord induced by a major HIV-envelope protein, gp120.

175 As a result, binding of the HIV-1 envelope protein gp120IIIB to the CD4/CXCR4/CCR5 heteroo

176 Cs and in this form preferentially bound HIV envelope protein gp140 and whole HIV particles via the c

177 Retargeting of gammaretroviral envelope proteins has shown promising results in the iso

178 ralizing antibodies that recognize the HIV-1 envelope protein have been isolated from these patients

179 N-linked glycans on the HIV-1 envelope protein have been postulated to contribute to v

180 us, this is manifested as a virion where the envelope proteins have multiple structures, the envelope

181 We find that two envelope proteins have to engage with CD4-receptors and

182 For example, in the influenza envelope protein hemagglutinin (HA), the low pH in the e

183 o account for antigenic changes in the viral envelope protein, hemagglutinin (HA).

184 The clusters of the influenza envelope protein, hemagglutinin, within the plasma membr

185 Sharing the same envelope proteins, hepatitis B virus and hepatitis delta

186 spread occurrence of O-glycans in regions of envelope proteins important for virus entry, formation,

187 nsgenic expression of a biotinylated nuclear envelope protein in the cell type of interest.

188 e number of O-glycosites distributed on most envelope proteins in all viruses and further demonstrate

189 ull-length and posttranslationally processed envelope proteins in cell culture.

190 tibody (Ab) response against the HCV and HBV envelope proteins in immunized animals.

191 t reduction of HBsAg secretion, retention of envelope proteins in the endoplasmic reticulum, less eff

192 Chimeric HBV-HCV envelope proteins in which the N-terminal transmembrane

193 We determined that SGHBV capsid and envelope proteins independently contribute to the produc

194 Although the envelope protein induced secretion of IL-1beta and TNF-a

195 ytoplasmic C-terminal tail of the HIV-1 gp41 envelope protein inhibited viral-initiated T-cell death

196 high selectivity for hepatocytes; the HBV L-envelope protein interacts specifically with a receptor

197 ) domain is conserved in a number of nuclear envelope proteins involved in nuclear migration, meiotic

198 human immunodeficiency virus type 1 (HIV-1) envelope protein is a major goal of vaccine strategies.

199 to an I-Ab-associated epitope of the F-MuLV envelope protein is dominated by clones expressing a Val

200 100 bp open reading frame (ORF) encoding the envelope proteins is fully nested within the ORF of the

201 l stiffness by overexpression of the nuclear envelope protein lamin A.

202 ells that overexpress the GFP-tagged nuclear envelope protein lamin A.

203 uman LMNA gene encodes the essential nuclear envelope proteins lamin A and C (lamin A/C).

204 hrough a reciprocal interaction with nuclear envelope proteins lamin A/C.

205 ations in the LMNA gene encoding the nuclear envelope proteins lamins A and C, represent a diverse gr

206 alternative fates: (i) envelopment by viral envelope proteins, leading to secretion extracellularly

207 T cells with a CAR specific for HBV envelope proteins localize to the liver in mice to reduc

208 japonicus, the conserved LEM-domain nuclear envelope protein Man1 ensures the formation of identical

209 The influenza virus hemagglutinin (HA) envelope protein mediates virus entry by first binding t

210 ough chromosome movement mediated by nuclear envelope proteins, microtubules, and dynein.

211 We refer to these hybrid biomaterials as 'enveloped protein nanocages' (EPNs).

212 Here, we identified the nuclear envelope protein nesprin-2 as a binding partner for fasc

213 ght chain (KLC)-binding motif in the nuclear envelope proteins nesprin-1 and nesprin-2, and show that

214 The hemagglutinin envelope protein of influenza plays a critical role in v

215 irus (AcMNPV) glycoprotein GP64 is the major envelope protein of the budded virus (BV).

216 0 nm FNDs with rA27(aa 21-84), a recombinant envelope protein of vaccinia virus, for glycosaminoglyca

217 This study examined how the envelope proteins of 25 variants of hepatitis B virus (H

218 Taking advantage of the fact that envelope proteins of different HIV-1 strains exhibit dif

219 of these properties are associated with the envelope proteins of HIV-1, it is of interest to study t

220 ins of HIV-1, it is of interest to study the envelope proteins of Indian clade C isolates as part of

221 Hemagglutinin-esterases (HEs) are bimodular envelope proteins of orthomyxoviruses, toroviruses, and

222 Although it is known that envelope proteins of several different viruses resist IF

223 ionary relationship among the three abundant envelope proteins of WSSV, our structural studies also f

224 tion with DNA expressing the premembrane and envelope proteins of ZIKV was immunogenic in mice and no

225 as associated with the immobilization of the envelope proteins on the cell surface.

226 the same Cp mutants in the cell without the envelope proteins or expressing and purifying the mutant

227 various extents by coexpression of wild-type envelope proteins or introduction of a novel glycosylati

228 Alphavirus envelope proteins, organized as trimers of E2-E1 heterod

229 We show that the envelope protein PilY1 and functional type IV pili are r

230 gument (located between the viral capsid and envelope proteins) play critical roles in the assembly a

231 The alphaherpesviral envelope protein pUS9 has been shown to play a role in t

232 ologies between the Zika and Dengue viruses' envelope proteins raise the possibility that cross-react

233 direct binding assay using a recombinant MLV envelope protein receptor binding domain (RBD).

234 unctional profile of Abs induced by an ALVAC/envelope protein regimen could be improved by substituti

235 ed, the precise organization of tegument and envelope proteins remains elusive.

236 lentiviruses or gammaretroviruses with their envelope proteins replaced with EBOV GP or pseudotyped w

237 ctivity results for two panels bearing viral envelope proteins representing either an intergenotype o

238 These data suggest that an accumulation of envelope proteins resulting from decreased vesiculation

239 ted similarities between G(C) and flavivirus envelope proteins reveal an evolutionary link between th

240 mediated by 20-nm-long homotrimers of spike envelope protein S.

241 cine, based on the remarkable ability of the envelope protein (S) of this virus to self-assemble into

242 meric antigen receptors (CARs) that bind HBV envelope proteins (S-CAR) and activate T cells were expr

243 zed soluble mutant forms of the dengue virus envelope protein (sE) that include portions of the juxta

244 lows users to analyze that data for each HIV Envelope protein sequence position and each antibody.

245 this R5 resistance pathway, we analyzed >500 envelope protein sequences and phenotypes from viruses o

246 of resistance to IFITM3 and that these HIV-1 envelope proteins share the same domain structure and si

247 In addition, Cohort 2 received recombinant envelope protein SIV-gp120.

248 conferred resistance to neutralization by an envelope protein-specific antibody.

249 ce, and Spumavirus-like particles with large envelope protein spikes and no visible electron density

250 velope dimer epitope (EDE), that bridges two envelope protein subunits that make up the 90 repeating

251 o neutralizing antibodies against major VACV envelope proteins, such as H3, D8, or A27, which failed

252 , cis-acting loci that interact with nuclear envelope proteins, such as SUN-1, to access cytoplasmic

253 structurally homologous to eukaryotic virus envelope proteins, suggesting that Archaea and viruses h

254 these analyses differ solely in their viral envelope proteins, suggesting that the block to XMRV and

255 Two families of nuclear envelope proteins, SUN and KASH, link the nucleus to the

256 harbor highly conserved sites on the exposed envelope protein surface of gp120, one of which is the v

257 na-associated protein LAP-1, myocyte nuclear envelope protein Syne1, BetaM itself, heme oxidases HMOX

258 conformational changes of specialized virus envelope proteins termed membrane fusion proteins.

259 have revealed the key features of the HIV-1 envelope protein that are associated with viral resistan

260 Nesprin-3 is a nuclear envelope protein that connects the nucleus to intermedia

261 e open reading frame (ORF) for the large (L) envelope protein that is essential for infectivity is pr

262 CE HSV-1 UL20 is a nonglycosylated essential envelope protein that is highly conserved among herpesvi

263 ighly conserved AB loop of domain III of the envelope protein that is poorly accessible in the mature

264 It is a nonglycosylated envelope protein that is regulated as a gamma1 gene.

265 cription of the gene encoding LBR, a nuclear envelope protein that is required for the characteristic

266 luenza virus hemagglutinin (HA) is the viral envelope protein that mediates viral attachment to host

267 tes have co-opted a viral gene to produce an envelope protein that prevents infection by the HERV-T v

268 discrete groups and distinguish areas of the envelope proteins that correlate with host specificity a

269 periplasmic chaperone/protease for misfolded envelope proteins that is critical when cells are heat s

270 matic subunits, bind cohesin modules of cell envelope proteins, thereby anchoring the cellulosome ont

271 plied cellPACK to model distributions of HIV envelope protein to test several hypotheses for consiste

272 Determining if the ability of SGHBV envelope proteins to cause the formation of virions cont

273 Manufacturing of ODV involves trafficking of envelope proteins to the inner nuclear membrane, mediate

274 art, to improper localisation of the nuclear envelope protein TPR.

275 genome replication, particle infectivity, or envelope protein transit to the cell surface.

276 he conformational transitions that the HIV-1 envelope protein undergoes during the course of entry in

277 umans via specific cleavage of the precursor envelope protein upstream of the transmembrane domain.

278 pared the trafficking of 15 integral nuclear envelope proteins using FRAP.

279 As one of the most abundant envelope protein, VP24 acts as a core protein interactin

280 is distinct to those of the other two major envelope proteins VP28 and VP26.

281 surface exposed, highly conserved peptide of Envelope protein was found to correspond to amino acid r

282 A PCP-consensus protein of a Dengue virus envelope protein was produced recombinantly and tested f

283 at targets the CD4-binding site of the HIV-1 envelope protein was used to engineer a next-generation

284 c cell-culture systems, expressing authentic envelope proteins, we demonstrated resistance of HCV to

285 gA and secretory IgA responses against HIV-1 envelope proteins were associated with reduced risk of p

286 ovirus genus, and two unexpectedly divergent envelope proteins were identified in families that also

287 ovirions displaying distinct influenza virus envelope proteins were tested for fusion activity.

288 JFH1(2a) and J8/JFH1(2b), all with authentic envelope proteins, were resistant to neutralization by g

289 ene encodes a 222-amino-acid nonglycosylated envelope protein which forms a complex with viral glycop

290 Vaccinia virus (VACV) L1 is a myristoylated envelope protein which is required for cell entry and th

291 in interacts with viral genetic material and envelope proteins while binding to the inner leaflet of

292 help identify critical residues on the HIV-1 envelope protein whose natural variation affects antibod

293 It encodes a membrane-bound envelope protein with fusogenic activity ex vivo, is exp

294 required to obtain high-affinity retargeted envelope proteins with narrow tropism are not understood

295 by linking the redox status of cysteine-rich envelope proteins with progression of the developmental

296 required specific interactions of the viral envelope proteins with the internal capsid protein.

297 eresting research material for defining cell-envelope proteins without experimental cell disruption.

298 HBV envelope proteins would individually bind to HS with low

299 ns) that express either the full length ZIKV envelope protein (ZENV) alone or include the ZENV precur

300 nalyze binding interactions between the zika envelope protein (ZENV) and proposed host cell receptors